Richard Scott Struthers, President & CEO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 10,000 shares at $25.00 ($250K) on 2021-09-07, disclosed to the SEC on 2021-09-09.
Open-market sale of $250k CRNX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CRNX | SELL | 2025-03-21 | $1.2M | — | Filing → |
| CRNX | SELL | 2024-12-04 | $576K | — | Filing → |
| CRNX | SELL | 2024-05-10 | $10.6M | — | Filing → |